We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$215M
AUM Growth
+$5.12M
Cap. Flow
-$12.1M
Cap. Flow %
-5.65%
Top 10 Hldgs %
32.15%
Holding
71
New
17
Increased
13
Reduced
23
Closed
12

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$5.41M
2
RVTY icon
Revvity
RVTY
+$4.91M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.67M
4
HCA icon
HCA Healthcare
HCA
+$4.38M
5
ABT icon
Abbott
ABT
+$4.32M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$9.29M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.42M
3
GILD icon
Gilead Sciences
GILD
+$5.73M
4
AZN icon
AstraZeneca
AZN
+$4.22M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 88.35%
2 Financials 3.26%
3 Energy 1.24%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.6B
$4.1M 1.91%
15,000
-5,000
-25% -$1.41M
THC icon
27
Tenet Healthcare
THC
$20.9B
$3.98M 1.86%
+225,000
New +$4.17M
COR icon
28
Cencora
COR
$62B
$3.98M 1.85%
45,000
-5,000
-10% -$439K
AZN icon
29
AstraZeneca
AZN
$251B
$3.89M 1.81%
62,500
-72,500
-54% -$4.22M
TMO icon
30
Thermo Fisher Scientific
TMO
$222B
$3.84M 1.79%
25,000
+5,000
+25% +$764K
BDX icon
31
Becton Dickinson
BDX
$48.9B
$3.67M 1.71%
20,500
-5,125
-20% -$893K
CAH icon
32
Cardinal Health
CAH
$55.5B
$2.85M 1.33%
+35,000
New +$2.75M
CHE icon
33
Chemed
CHE
$7.18B
$2.74M 1.28%
15,000
– –
LHCG
34
DELISTED
LHC Group LLC
LHCG
$2.66M 1.24%
49,405
+14,405
+41% +$700K
BCR
35
DELISTED
CR Bard Inc.
BCR
$2.48M 1.16%
10,000
-10,000
-50% -$2.41M
VTRS icon
36
Viatris
VTRS
$18.7B
$2.34M 1.09%
+60,000
New +$2.42M
ACAD icon
37
Acadia Pharmaceuticals
ACAD
$5.06B
$2.23M 1.04%
65,000
-5,000
-7% -$176K
PRXL
38
DELISTED
Parexel International Corp
PRXL
$2.21M 1.03%
35,000
+5,000
+17% +$331K
BHC icon
39
Bausch Health
BHC
$2.37B
$2.21M 1.03%
+200,000
New +$2.75M
ACHC icon
40
Acadia Healthcare
ACHC
$2.96B
$2.18M 1.02%
+50,000
New +$2.03M
SNN icon
41
Smith & Nephew
SNN
$12.6B
$2.17M 1.01%
70,000
-15,000
-18% -$459K
IPXL
42
DELISTED
Impax Laboratories, Inc.
IPXL
$2.13M 0.99%
168,030
+63,030
+60% +$761K
AMED
43
DELISTED
Amedisys
AMED
$1.77M 0.82%
34,607
+13,097
+61% +$625K
ISRG icon
44
Intuitive Surgical
ISRG
$139B
$1.73M 0.8%
20,250
-6,750
-25% -$533K
ILMN icon
45
Illumina
ILMN
$29B
$1.71M 0.79%
+10,280
New +$1.62M
PRGO icon
46
Perrigo
PRGO
$1.75B
$1.66M 0.77%
+25,000
New +$1.9M
TSRO
47
DELISTED
TESARO, Inc.
TSRO
$1.62M 0.75%
+10,500
New +$1.71M
DPLO
48
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.61M 0.75%
+101,000
New +$1.46M
TEVA icon
49
Teva Pharmaceuticals
TEVA
$42.1B
$1.6M 0.75%
+50,000
New +$1.71M
RMD icon
50
ResMed
RMD
$31.9B
$1.53M 0.71%
21,200
-23,800
-53% -$1.64M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q1 2017 Portfolio in Review

As of Q1 2017, Sivik Global Healthcare held 71 positions worth $215M, up 2.4% from $210M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Sivik Global Healthcare withdrew a net $12.1M in Q1 2017, closing 12 positions and reducing 23 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $9.29M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 83% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Baxter International worth $5.71M.

  • Sivik Global Healthcare's largest Q1 2017 buy was Baxter International: 110,000 shares worth $5.71M.
  • Sivik Global Healthcare added most to Eli Lilly in Q1 2017, an estimated $4M increase.
  • Sivik Global Healthcare's biggest Q1 2017 reduction was AstraZeneca, cutting an estimated $4.22M.
  • Sivik Global Healthcare fully exited iShares Biotechnology ETF in Q1 2017, selling an estimated $9.29M.
  • Sivik Global Healthcare's ten largest holdings make up 32% of its $215M portfolio in Q1 2017.
  • Sivik Global Healthcare opened 17 new positions and closed 12 in Q1 2017.
  • Sivik Global Healthcare's portfolio value rose 2.4% quarter-over-quarter to $215M.

Based on Sivik Global Healthcare's 13F filing for Q1 2017, filed 11 May 2017.